Clinical trial
Alzheimer's Disease Long-term Follow-up Study (ALF Study)
NCT00165724 · Eisai Korea Inc., Industry · Completed
Key facts
| NCT number | NCT00165724 |
|---|---|
| Title | Alzheimer's Disease Long-term Follow-up Study (ALF Study) |
| Official title | Alzheimer's Disease Long-term Follow-up Study (ALF Study) |
| Lead sponsor | Eisai Korea Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Donepezil Hydrochloride |
| Enrollment | 114 |
| Start date | Jun 30, 2004 |
| Primary completion | Jul 31, 2006 |
| Completion | Dec 31, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Dec 30, 2021 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: